Mankind Pharma shares drop 3% post Q2
Mankind Pharma has reported 19.4% YoY rise in profit at ₹501.03 cr in Q2 FY24, while revenue from operations jumped 11.6% to ₹2,708.10 cr.
manforce condoms
November 2023
May 2023
April 2023
September 2022
Mankind Pharma makes stellar debut; lists at 20% premium
The Delhi-based healthcare company raised ₹4,326 crore in the country’s biggest IPO so far this year, which was subscribed 15.32 times on the back of strong response from QIBs.
Mankind Pharma to launch IPO this month; looks to raise around ₹4,700 cr
The IPO of the country’s fourth largest pharma company by domestic sales comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.
Mankind Pharma files draft prospectus for IPO
The IPO comprises an offer for sale (OFS) of 4 crore equity shares by the company's promoters and existing shareholders.
